CINECA IRIS Institutional Research Information System

MARTINI, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.902
EU - Europa 1.265
AS - Asia 879
SA - Sud America 73
AF - Africa 26
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.158
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.854
CN - Cina 551
IT - Italia 384
FR - Francia 117
DE - Germania 112
IE - Irlanda 112
SE - Svezia 106
ES - Italia 70
GB - Regno Unito 65
AT - Austria 62
IN - India 53
KR - Corea 44
BE - Belgio 43
JP - Giappone 40
UA - Ucraina 35
BR - Brasile 32
CA - Canada 31
TR - Turchia 31
VN - Vietnam 28
FI - Finlandia 27
HK - Hong Kong 23
PL - Polonia 20
NL - Olanda 19
EG - Egitto 18
AR - Argentina 17
PT - Portogallo 17
RU - Federazione Russa 17
MX - Messico 14
SG - Singapore 13
PH - Filippine 12
TH - Thailandia 12
CO - Colombia 11
GR - Grecia 11
RO - Romania 11
TW - Taiwan 11
ID - Indonesia 10
UZ - Uzbekistan 10
AU - Australia 9
SA - Arabia Saudita 9
PE - Perù 8
DK - Danimarca 7
IR - Iran 6
BA - Bosnia-Erzegovina 5
CH - Svizzera 5
IL - Israele 5
LB - Libano 5
MY - Malesia 5
NO - Norvegia 5
MA - Marocco 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
EU - Europa 3
MM - Myanmar 3
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
EE - Estonia 2
HU - Ungheria 2
LT - Lituania 2
LU - Lussemburgo 2
SN - Senegal 2
SV - El Salvador 2
BD - Bangladesh 1
BG - Bulgaria 1
GT - Guatemala 1
HR - Croazia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 4.158
Salva come PNG Salva come JPEG
Città #
Chandler 358
Beijing 169
Dublin 112
Fairfield 103
Nyköping 75
Ann Arbor 70
Fremont 69
Torino 59
Vienna 59
Villeurbanne 53
Houston 50
Dearborn 49
Redwood City 48
Woodbridge 46
Cambridge 43
New York 42
Ashburn 41
Hangzhou 41
Medford 40
Wilmington 40
Princeton 39
Milan 31
Guangzhou 30
Jacksonville 27
Pisa 27
Rome 27
Shanghai 27
Turin 27
Brussels 25
Barcelona 22
Hebei 19
Seattle 19
Chengdu 17
Delhi 17
Paris 15
Warsaw 15
London 14
Nanjing 14
Tokyo 14
Dong Ket 13
Hanover 13
Chongqing 12
Los Angeles 12
Berlin 11
Central 11
Rimini 11
Seoul 11
Cairo 10
Hefei 10
Jakarta 10
Toronto 10
Chicago 9
Istanbul 9
Nanning 9
Osaka 9
Washington 9
Boston 8
Kiel 8
Kunming 8
San Diego 8
São Paulo 8
Upper Marlboro 8
Bologna 7
Lima 7
Padova 7
Tianjin 7
Buenos Aires 6
Columbus 6
Fuzhou 6
Gent 6
Jena 6
Monza 6
Naples 6
Norwalk 6
Ottawa 6
Rotterdam 6
Singapore 6
Wuhan 6
Xian 6
Bordeaux 5
Bursa 5
Changsha 5
Copenhagen 5
Diamond Bar 5
Duncan 5
Friedrichsdorf 5
Hanoi 5
Helsinki 5
Kuala Lumpur 5
Lisbon 5
Madison 5
Marsciano 5
Newbury Park 5
Porto Alegre 5
Seville 5
Shenzhen 5
Yangsan 5
Bangalore 4
Boardman 4
Bucharest 4
Totale 2.428
Salva come PNG Salva come JPEG
Nome #
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 1.301
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis 300
Extracellular Vesicles from Human Liver Stem Cells Reduce Injury in an Ex Vivo Normothermic Hypoxic Rat Liver Perfusion Model 265
Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers 145
SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 115
ALL ORAL SOFOSBUVIR-BASED ANTIVIRAL THERAPY IN LIVER TRANSPLANT RECIPIENTS AFFECTED BY MODERATE-SEVERE HEPATITIS C RECURRENCE: PREDICTORS OF VIRAL RESPONSE AND SURVIVAL 106
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 104
Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C recipients 102
FEASIBILITY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY BEFORE LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A MONOCENTRIC EXPERIENCE 99
SOFOSBUVIR PLUS RIBAVIRIN BEFORE OR ACROSS LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A SINGLE CENTRE EXPERIENCE 99
SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 93
Antiviral Therapy With Sofosbuvir Plus Ribavirin Before Or Across Liver Transplantation To Prevent HCV Recurrence: Preliminary Data from a Single Centre Experience 87
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 84
Carrying on with liver transplantation during the COVID-19 emergency: Report from Piedmont region 84
SAFETY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY IMMEDIATELY AFTER LIVER TRANSPLANTATION: A MATCHED CASE-CONTROL ANALYSIS 81
Successful urgent liver retransplantation for donor-transmitted hepatocellular carcinoma 78
IMMUNOGENETIC FACTORS AFFECT SURVIVAL IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS 77
Liver transplantation for patients with HCV-related end-stage liver disease and undetectable HCV-RNA: the Turin Centre experience 74
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 73
Outcomes of Liver Transplantation in Simultaneously Hepatitis BSurface Antigen and Hepatitis C Virus RNA Positive Recipients: TheDeleterious Effect of Donor Hepatitis B Core Antibody Positivity 70
Oral Surgical Treatment of Patients With Chronic Liver Disease: Assessments of Bleeding and Its Relationship With Thrombocytopenia and Blood Coagulation Parameters 70
Long-Term Outcome of Veno-Occlusive Disease After Liver Transplant: A Retrospective Single-Center Experience 68
Outcomes of Liver Transplantation from Hepatitis B CoreAntibody–Positive Donors in Viral Cirrhosis Patients: The PrevailingNegative Effect of Recipient Hepatitis C Virus Infection 64
Two Combined Genetic Markers Identify Hepatitis C Recipients With a Lower Graft Survival From The Earliest Post-Transplant Period 63
HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals? 61
Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping? 61
Early and Late Hepatitis B Reactivation after IFN- or DAA-based Therapy of Recurrent Hepatitis C in Anti-HBc-positive Liver Transplant Recipients 60
Urgent liver transplantation soon after recovery from COVID-19 in a patient with decompensated liver cirrhosis 59
Seroconversion After Coronavirus Disease 2019 Vaccination in Patients Awaiting Liver Transplantation: Fact or Fancy? 58
SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 57
The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease 55
Reply to: Seroconversion after COVID-19 vaccination (LT-21-741) 54
Severe Passenger Lymphocyte Syndrome and Acute Rejection in ABO Compatible but non-Identical Liver Transplant Recipient from Hepatitis C Viremic Donor 46
Seroprevalence of Hepatitis E Virus in liver transplant patients in Turin, Italy. 21
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS) 18
Early post-liver transplant use of direct-acting antivirals in naive and NS5A inhibitor-experienced HCV patients 13
Coronavirus disease 2019 (COVID-19) vaccination in patients with cirrhosis: Does it work? 13
Solid non-lung organs from COVID-19 donors in seropositive or naive recipients: Where do we stand? 11
Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients 9
Extracellular Vesicles in Liver Transplantation: Current Evidence and Future Challenges 8
Favorable experience of transplant strategy including liver grafts from COVID-19 donors: One-year follow-up results 3
Functional evaluation of right coronary artery with anomalous origin in cirrhotic liver transplant candidate 2
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 2
Comparative evaluation of serologic tests for celiac disease diagnosis and follow-up 2
Fecal microbiota transplantation before liver transplant in patient colonized with New Delhi metallo-beta-lactamase: Are we ready for a sequential approach? 1
Totale 4.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.362
article - articoli 0
book - libri 0
conference - conferenze 3.147
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.509
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201960 0 0 0 0 0 0 0 0 0 0 40 20
2019/2020337 10 15 13 50 16 58 39 29 29 34 23 21
2020/2021424 19 27 13 12 21 26 36 36 40 38 63 93
2021/2022952 60 44 70 51 118 109 54 57 52 62 142 133
2022/20231.188 100 107 75 106 80 203 64 116 119 52 101 65
2023/2024692 93 90 65 47 84 106 63 56 27 61 0 0
Totale 4.316